Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.lanmic.2024.101066 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Decade-Long Trends in Antibiotic Prescriptions According to WHO AWaRe Classification Among Severe Acute Respiratory Infection Patients at Tertiary Hospitals in Bangladesh (2011-2020).
Antibiotics (Basel)
February 2025
The Eastern Mediterranean Public Health Network (EMPHNET), Dhaka 1212, Bangladesh.
To aid in the development of antimicrobial stewardship programs (ASPs), we analyzed the patterns and trends in antibiotic prescriptions for patients with severe acute respiratory infection (SARI), utilizing the WHO's AWaRe classification. We analyzed data from hospital-based influenza surveillance from January 2011 to December 2020 across nine Bangladeshi tertiary-level hospitals. Surveillance physicians collected WHO-defined SARI patient data, including demographics, clinical characteristics, and antibiotic prescriptions.
View Article and Find Full Text PDFNational-Level Consumption of Antimicrobials in the Veterinary Sector in Uganda: A Report on Analysis of Import Data for 2021.
Antibiotics (Basel)
February 2025
USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, VA 22203, USA.
Background: Antimicrobials are crucial for animal health and food security. However, their overuse in animals can lead to the emergence of resistant microorganisms. Antimicrobial resistance (AMR) poses a global public health threat that impacts both animal and human health.
View Article and Find Full Text PDFUpdate on MDR-TB preventive therapy towards the global TB elimination.
Int J Infect Dis
February 2025
Clinic of Infectious and Tropical Diseases, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Multidrug-resistant tuberculosis (MDR-TB), the deadliest form of TB, has been included in the 2024 WHO's priority list of antibiotic resistant bacterial pathogens due to its severe public health implications. Almost 2 billion people are infected by TB worldwide, but the burden of MDR-TB infection remains uncertain. Mathematics modelling estimates that MDR-TB affects nearly three in every 1,000 people globally, highlighting the urgent need to address tuberculosis preventive treatment (TPT) for contacts of MDR-TB cases.
View Article and Find Full Text PDF[Annual progress of new drugs and new regimens for anti-tuberculosis treatment (2024)].
Zhonghua Jie He He Hu Xi Za Zhi
February 2025
Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Research Institute, Beijing 101149, China.
China remains one of the countries with a high burden of tuberculosis (TB), with an estimated 748, 000 cases each year, ranking third in the world. The research and development of new drugs and new protocols plays a key role in the face of the requirements of the WHO's End TB Strategy. There are multiple new drugs in the clinical trial stage, such as macozinone, sutezoid, alpiberctin, and GSK3036656.
View Article and Find Full Text PDFWHO's antibiotic waste management guidelines: advancements and shortcomings.
Lancet Microbe
January 2025
Department of Pharmacology, Faculty of Medicine, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu 603203, India. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!